Tumor-associated antigen-specific cytotoxic T-lymphocytes (TAA-CTLs)

· Baylor College of Medicine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tumor-associated antigen-specific cytotoxic T-lymphocytes (TAA-CTLs), covering 2026-02-25 to 2026-02-25. Get the full timeline:

Most recent: Clinical Trial Update: Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma [Phase 1]

See pricing